Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0116) is a clinical research site located in Mineola, New York, United States 11501.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0116) has participated in 1 clinical trials.
Therapeutic areas: High-grade Serous Ovarian Carcinoma, Ovarian Carcinoma.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0116) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0116) has 1 clinical trials on record. Their work covers High-grade Serous Ovarian Carcinoma, Ovarian Carcinoma.
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0116) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.